PHK
EPZM

Point72 Hong Kong’s Epizyme, Inc EPZM Stock Holding History

Point72 Hong Kong’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,841
Closed -$17K – 2573
2022
Q1 		$17K Buy
14,841
+2,159
+17% +$3.52K ﹤0.01% 1547
2021
Q4 		$32K Sell
12,682
-183
-1% -$719 ﹤0.01% 1462
2021
Q3 		$66K Buy
12,865
+10,963
+576% +$66.6K ﹤0.01% 1456
2021
Q2 		$16K Sell
1,902
-1,371
-42% -$11.6K ﹤0.01% 1673
2021
Q1 		$29K Sell
3,273
-2,422
-43% -$25.1K ﹤0.01% 1404
2020
Q4 		$62K Buy
5,695
+4,791
+530% +$59.1K ﹤0.01% 1169
2020
Q3 		$11K Sell
904
-9,275
-91% -$124K ﹤0.01% 984
2020
Q2 		$163K Buy
10,179
+9,654
+1,839% +$169K 0.02% 540
2020
Q1 		$8K Buy
+525
New +$11.3K ﹤0.01% 727
2019
Q2 		– Sell
-314
Closed -$4K – 1496
2019
Q1 		$4K Buy
+314
New +$3.51K ﹤0.01% 847
2018
Q3 		– Sell
-30
Closed – – 1280
2018
Q2 		$0 Sell
30
-1,869
-98% -$29.1K ﹤0.01% 1280
2018
Q1 		$34K Buy
1,899
+1,854
+4,120% +$31.3K 0.02% 538
2017
Q4 		$1K Sell
45
-169
-79% -$2.46K ﹤0.01% 805
2017
Q3 		$4K Buy
+214
New +$3.27K ﹤0.01% 603

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Hong Kong's EPZM Position: Q2 2022 in Review

Point72 Hong Kong sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 14,841 shares — an estimated $17K sold.

Point72 Hong Kong first reported a position in EPZM in Q3 2017 and held it in 14 quarters. The position peaked at $163K in Q2 2020. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Point72 Hong Kong reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 14,841 Epizyme, Inc shares in Q2 2022, an estimated $17K.
  • Point72 Hong Kong first reported a position in Epizyme, Inc in Q3 2017 and held it in 14 quarters.
  • Point72 Hong Kong's Epizyme, Inc position peaked at $163K in Q2 2020.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.